BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2288834)

  • 1. Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.
    Raghoebar M; Mak M; Cournot A; Pistorius MC; Van Harten J; Roseboom H
    Br J Clin Pharmacol; 1990 Dec; 30(6):879-83. PubMed ID: 2288834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of eltoprazine in the dog.
    Lammers R; van Harten J
    Drug Metabol Drug Interact; 1990; 8(1-2):141-8. PubMed ID: 2091887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-proportionality of eltoprazine. Pharmacokinetics of single oral doses in healthy subjects.
    de Vries MH; de Koning P; Floot HL; Grahnén A; Eckernäs SA; Raghoebar M; Dahlström B; Ekman L
    Eur J Clin Pharmacol; 1991; 41(5):485-8. PubMed ID: 1761079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers.
    Iovino M; Feifel U; Yong CL; Wolters JM; Wallenstein G
    Cephalalgia; 2004 Aug; 24(8):645-56. PubMed ID: 15265053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
    Nichols DJ; Muirhead GJ; Harness JA
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):5S-12S. PubMed ID: 11879254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of eltoprazine in healthy subjects.
    van Harten J; Mathlener IS; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):149-58. PubMed ID: 2091888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terazosin kinetics after oral and intravenous doses.
    Patterson SE
    Clin Pharmacol Ther; 1985 Oct; 38(4):423-7. PubMed ID: 4042526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
    Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y; Kim A; Lee S; Choi SH; Lee DY; Song JS; Lee H; Jang IJ; Yu KS
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and food interaction of MK-462 in healthy males.
    Cheng H; Polvino WJ; Sciberras D; Yogendran L; Cerchio KA; Christie K; Olah TV; McLoughlin D; James I; Rogers JD
    Biopharm Drug Dispos; 1996 Jan; 17(1):17-24. PubMed ID: 8991488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose safety and pharmacokinetics of a potential cognition-enhancing compound, CL 275,838, in healthy volunteers.
    Caccia S; Confalonieri S; Guiso G; Lucca U; Parma E; Guido M; Tettamanti M; Tiraboschi P; Spagnoli A
    J Clin Pharmacol; 1993 Sep; 33(9):845-50. PubMed ID: 8227482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
    Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Langer M; Barlage U; Hiemke C
    Psychopharmacology (Berl); 1994 Dec; 116(4):457-63. PubMed ID: 7701049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients.
    Okamura Y; Shigemasa C; Tatsuhara T
    Endocrinol Jpn; 1986 Oct; 33(5):605-15. PubMed ID: 3830069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
    Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.